240 related articles for article (PubMed ID: 8882706)
1. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
Sato H; Seiki M
J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
[TBL] [Abstract][Full Text] [Related]
2. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
3. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
Pei D; Weiss SJ
J Biol Chem; 1996 Apr; 271(15):9135-40. PubMed ID: 8621565
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
6. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP; Will H; Atkinson S; Butler G; Messent A; Gavrilovic J; Smith B; Timpl R; Zardi L; Murphy G
Eur J Biochem; 1997 Dec; 250(3):751-7. PubMed ID: 9461298
[TBL] [Abstract][Full Text] [Related]
7. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
8. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
9. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
Sato H; Takino T; Kinoshita T; Imai K; Okada Y; Stetler Stevenson WG; Seiki M
FEBS Lett; 1996 May; 385(3):238-40. PubMed ID: 8647259
[TBL] [Abstract][Full Text] [Related]
10. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for pro matrix metalloproteinase activation.
Murphy G; Stanton H; Cowell S; Butler G; Knäuper V; Atkinson S; Gavrilovic J
APMIS; 1999 Jan; 107(1):38-44. PubMed ID: 10190278
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
[TBL] [Abstract][Full Text] [Related]
13. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis.
Tokuraku M; Sato H; Murakami S; Okada Y; Watanabe Y; Seiki M
Int J Cancer; 1995 Oct; 64(5):355-9. PubMed ID: 7591310
[TBL] [Abstract][Full Text] [Related]
14. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.
Foda HD; George S; Conner C; Drews M; Tompkins DC; Zucker S
Lab Invest; 1996 Feb; 74(2):538-45. PubMed ID: 8780171
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
16. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
17. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.
Sang QA; Bodden MK; Windsor LJ
J Protein Chem; 1996 Apr; 15(3):243-53. PubMed ID: 8804571
[TBL] [Abstract][Full Text] [Related]
18. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
Yoshizaki T; Sato H; Maruyama Y; Murono S; Furukawa M; Park CS; Seiki M
Cancer; 1997 Jan; 79(1):139-44. PubMed ID: 8988738
[TBL] [Abstract][Full Text] [Related]
20. Gelatinases A and B.
Murphy G; Crabbe T
Methods Enzymol; 1995; 248():470-84. PubMed ID: 7674939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
